Oral cholera vaccine protects against endemic disease, real life trial showsBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3730 (Published 09 July 2015) Cite this as: BMJ 2015;351:h3730
- Susan Mayor
An oral cholera vaccine given as part of routine healthcare protects against severe cholera in children and adults in urban Bangladesh, where the disease is endemic, a real life trial of the vaccine has shown.1
The open label study, reported in the Lancet and funded by the Bill and Melinda Gates Foundation, included almost 270 000 people aged 1 and over living in the urban slums of Mirpur in Dhaka, Bangladesh. Researchers randomly assigned 90 geographical clusters of people to three groups: vaccination with a killed whole cell oral cholera vaccine (Shanchol); vaccination and behaviour change promoting handwashing …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial